Table 3.
Shows the Diverse Retinal Diagnosis and a Categorization of the Degree of Visual Impairment
| Mild Visual Impairment/Near Normal Freq (%) | Moderate Visual Impairment Freq (%) | Severe Visual Impairment Freq (%) | Blindness Freq (%) | Total | |
|---|---|---|---|---|---|
| BRAO | 0 (0.0%) | 1 (50.0%) | 1 (50.0%) | 0 (0.0%) | 2 (100.0%) |
| BRVO | 7 (25.0%) | 8 (28.6%) | 1 (3.6%) | 12 (42.9%) | 28 (100.0%) |
| Choroidal rupture | 0 (0.0%) | 1 (33.3%) | 0 (0.0%) | 2 (66.7%) | 3 (100.0%) |
| CMO | 0 (0.0%) | 7 (63.6%) | 1 (9.1%) | 3 (27.3%) | 11 (100.0%) |
| CNVM | 2 (40.0%) | 2 (40.0%) | 1 (20.0%) | 0 (0.0%) | 5 (100.0%) |
| CRAO | 1 (14.3%) | 0 (0.0%) | 0 (0.0%) | 6 (85.7%) | 7 (100.0%) |
| CRVO | 4 (8.5%) | 7 (14.9%) | 5 (10.6%) | 31 (66.0%) | 47 (100.0%) |
| CSR | 0 (0.0%) | 10 (90.9%) | 0 (0.0%) | 1 (9.1%) | 11 (100.0%) |
| Diabetic maculopathy | 28 (35.0%) | 30 (37.5%) | 9 (11.2%) | 13 (16.3%) | 80 (100.0%) |
| Diabetic retinopathy | 77 (39.3%) | 49 (25.0%) | 10 (5.1%) | 60 (30.6%) | 196 (100.0%) |
| Diabetic retinopathy with maculopathy | 50 (37.9%) | 50 (37.9%) | 12 (9.1%) | 20 (15.1%) | 132 (100.0%) |
| Dry AMD | 53 (42.7%) | 40 (32.3%) | 7 (5.6%) | 24 (19.4%) | 124 (100.0%) |
| ERM | 7 (63.6%) | 2 (18.2%) | 1 (9.1%) | 1(9.1%) | 11 (100.0%) |
| HIV retinopathy | 0 (0.0%) | 1 (33.3%) | 0 (0.0%) | 2 (66.7%) | 3 (100.0%) |
| Hypertensive retinopathy | 43 (79.6%) | 5 (9.3%) | 2 (3.7%) | 4 (7.4%) | 54 (100.0%) |
| HRVO | 1 (20.0%) | 2 (40.0%) | 0 (0.0%) | 2 (40.0%) | 5 (100.0%) |
| PCV | 2 (11.1%) | 2 (11.1%) | 2 (11.1%) | 12 (66.7%) | 18 (100.0%) |
| Leukaemic retinopathy | 0 (0.0%) | 1 (25.0%) | 0 (0.0%) | 3 (75.0%) | 4 (100.0%) |
| Macular hole | 3 (11.1%) | 11 (40.7%) | 5 (18.5%) | 8 (29.6%) | 27 (100.0%) |
| Neuroretinitis | 0 (0.0%) | 1 (25.0%) | 0 (0.0%) | 3 (75.0%) | 4 (100.0%) |
| No view due to dense cataract | 0 (0.0%) | 0 (0.0%) | 3 (13.6%) | 19 (86.4%) | 22 (100.0%) |
| Other chorioretinitis | 5 (19.2%) | 8 (30.8%) | 1 (3.8%) | 12 (46.2%) | 26 (100.0%) |
| Retinal dystrophy | 3 (17.6%) | 6 (35.3%) | 6 (35.3%) | 2 (11.8%) | 17 (100.0%) |
| Pathological myopia | 2 (4.1%) | 11 (22.4%) | 10(20.4%) | 26 (53.1%) | 49 (100.0%) |
| PED | 2 (100.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 2 (100.0%) |
| PSCR | 5 (50.0%) | 1 (10.0%) | 3 (30.0%) | 1 (10.0%) | 10 (100.0%) |
| PVD | 25 (64.1%) | 6 (15.4%) | 2 (5.1%) | 6 (15.4%) | 39 (100.0%) |
| Retinoblastoma | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 2 (100.0%) | 2 (100.0%) |
| Retinal detachment | 11 (5.2%) | 36 (16.0%) | 18 (7.5%) | 154 (71.4%) | 219 (100.0%) |
| Peripheral Retinal degeneration | 20 (60.6%) | 7 (21.2%) | 1 (3.0%) | 5 (15.2%) | 33 (100.0%) |
| Retinal scar | 12 (27.9%) | 16(37.2%) | 6 (14.0%) | 9 (20.9%) | 43 (100.0%) |
| Retinitis sclopetaria | 0 (0.0%) | 0 (0.0%) | 1 (50.0%) | 1 (50.0%) | 2 (100.0%) |
| Retinal tear | 7 (70.0%) | 1 (10.0%) | 1 (10.0%) | 1 (10.0%) | 10 (100.0%) |
| ROP | 1 (50.0%) | 0 (0.0%) | 0 (0.0%) | 1 (50.0%) | 2 (100.0%) |
| Retinitis pigmentosa | 16 (28.6%) | 19 (33.9%) | 6 (10.7%) | 15 (26.8%) | 56 (100.0%) |
| SCR | 3 (42.9%) | 1 (14.3%) | 1 (14.3%) | 2 (28.6%) | 7 (100.0%) |
| Trauma | 5 (13.5%) | 12 (32.4%) | 0 (0.0%) | 20 (54.1%) | 37 (100.0%) |
| Uveitis | 7 (21.9%) | 9 (28.1%) | 5 (15.6%) | 11 (34.4%) | 32 (100.0%) |
| Valsalva retinopathy | 1 (50.0%) | 0 (0.0%) | 0 (0.0%) | 1 (50.0%) | 2 (100.0%) |
| Vasculitis | 1 (25.0%) | 3 (75.0%) | 0 (0.0%) | 0 (0.0%) | 4 (100.0%) |
| VMT | 0 (0.0%) | 6 (75.0%) | 1 (12.5%) | 1 (12.5%) | 8 (100.0%) |
| Wet AMD | 6 (18.8%) | 19 (59.4%) | 3 (9.4%) | 4 (12.5%) | 32 (100.0%) |
| Total | 1426 (100.0%) |